McMurray JJ, Abraham WT, Dickstein K, K ber L, Massie BM, Krum H. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail. 2012;14:341 343. 120. Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev. 2009:CD004349. 121. Elliott WJ. What should be the blood pressure target for diabetics? Curr Opin Cardiol. 2011;26:308 313. 122. Upadhyay A, Earley A, Haynes SM, Uhlig K. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154:541 548. 123. Izzo JL Jr, Gradman AH. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Med Clin North Am. 2004;88:1257 1271. Rosendorff et al Treatment of Hypertension in Patients With CAD 1403 124. Vasan RS, Larson MG, Leip EP, Evans JC, O Donnell CJ, Kannel WB, Levy D. Impact of high normal blood pressure on the risk of cardiovas- cular disease. N Engl J Med. 2001;345:1291 1297. 125. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR; Women s Health Initiative Investigators. Prehypertension and cardiovascular disease risk in the Women s Health Initiative. Circulation. 2007;115:855 860. 126. Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, Hirakawa Y, Matsumura K, Kitazono T, Kiyohara Y. Impact of lower range of prehypertension on cardiovascular events in a general popula- tion: the Hisayama Study. J Hypertens. 2012;30:893 900. 127. Canty JM Jr. Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res. 1988;63:821 836. 128. Harrison DG, Florentine MS, Brooks LA, Cooper SM, Marcus ML. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation. 1988;77:1108 1115. 129. 